Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 20 April 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Lethal hospital bug cases rocket

A new strain of C. difficile is difficult to eradicate from the ward, causing an excess number of cases, as well as more severe cases that make patients very ill, reports the BBC.

News image

fiogf49gjkf04

Clostridium difficile is not resistant to treatment, but some cases are difficult to treat.

The strain seen at Stoke Mandeville hospital in England is related to one which has emerged in the USA and Canada.

The number of cases of a potentially lethal hospital infection has rocketed since the 1990s, figures show.

The Department of Health has revealed there were 44,488 cases of C. difficile in over 65s in England last year.

The BBC News reports that this was the first time mandatory surveillance of the diarrhoea-causing infection has been undertaken.

In the early 1990s there were about 1,000 cases a year, but by 2003 the total rose to 35,536, England, Wales and Northern Ireland data showed.

However, this was only collected on a voluntary basis so the true figure may have been higher.

These latest statistics have showed that C.difficile is nearly 7 times more common than MRSA, although the superbug is more deadly.

C. difficile cannot be destroyed by hand gels, whereas MRSA can
BBC News

The Office for National Statistics data has showed C.difficile was the underlying cause of 934 deaths in 2003, a similar number linked to MRSA.

The Department of Health also released figures for the number of cases of GRE, a bug which can cause wound infections and occasionally blood poisoning.”

Although hard to treat it is not particularly virulent compared to other hospital infections, with just 620 cases.

Chief nursing officer Christine Beasley said some of the rise in infections was down to better reporting.

”This is largely due to the fact that medical care advances were keeping people alive for longer, making them more susceptible to bugs.

"The immune system does not work as well and, therefore, people are more vulnerable.”

C. difficile will now be included in the government programme to fight MRSA.

C. difficile usually affects the elderly, although young people have been affected.

This infection can prove fatal if antibiotic treatment fails to kill all the spores in the gut.

It is also very difficult to eradicate from the ward environment, which means it is easy for other patients to become infected.

The spores of C. difficile cannot be destroyed by hand gels, whereas MRSA can.

Experts have said staff must use soap and water to get rid of the bug.

The BBC also reports that hospital wards must be cleaned using more powerful disinfectants than usual to eradicate the bug.

Professor Mark Willcox is a consultant medical microbiologist who works on a C. difficile standards group that reported to the Department of Health.

Professor Willcox told the BBC "The most worrying concern is not so much how many cases we are having, but this new strain which appeared first in Canada about 2 or 3 years ago.”

"It appears to cause an excess number of cases when it occurs in a hospital, but the particularly worrisome thing is that it causes more severe cases - patients can be very ill with this strain."

BBC News 2005, 26 August, 09:29 GMT
29 August 2005

Go to top of page Email this page Email this page to a colleague

 20 April 2018 
Obesity and physical activity in diverticulosis
 20 April 2018 
Worldwide H.pylori prevalence
 20 April 2018 
Adalimumab with azathioprine in Crohn's
 20 April 2018 
Antibody suitable for further clinical development to complement existing therapeutic strategies for HCV
 19 April 2018 
Fibrosis in patients with chronic hepatitis B
 19 April 2018 
c-Myc expression and pancreatic cancer
 19 April 2018 
Olmesartan prescription in the USA
 18 April 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 18 April 2018 
Hep C treatment for sustained virologic response
 18 April 2018 
Endoscopic necrosectomy reduces risk of death 
 17 April 2018 
Colorectal cancer screening and ethnic inequities
 17 April 2018 
Training programs should consider radiation education for advanced endoscopy fellows
 17 April 2018 
Aspirin and pancreatic cancer
 16 April 2018 
Surgery for colorectal polyps has increased 
 16 April 2018 
Advanced fibrosis can be ruled out in primary health care patients
 16 April 2018 
Antibiotic use and colorectal adenoma
 13 April 2018 
Colorectal cancer cell lines
 13 April 2018 
Infliximab and corticosteroid-free clinical remission in Crohn's
 13 April 2018 
Teduglutide for children with short bowel syndrome
 12 April 2018 
Prescriptions for opiate drugs amongst primary care patients with IBD
 12 April 2018 
Lower GI bleeding related to comorbidity
 12 April 2018 
non–Clostridium difficile bacterial infections in IBD
 11 April 2018 
Physician perception of IBD trial results
 11 April 2018 
Bile acid deficiency in IBS 
 11 April 2018 
Stem cell therapy for fistulas in Crohn's
 10 April 2018 
Overweight in childhood and type 2 diabetes
 10 April 2018 
immunoglobulin G associates with clinical features of IBD
 10 April 2018 
T-cells repertoires in celiac disease
 09 April 2018 
Biomarker tests for colorectal cancer screening
 09 April 2018 
Fecal transplantation in C. difficile infection and treatment outcome 
 09 April 2018 
No weigh-loss drug improved all cardiometabolic risk factors
 06 April 2018 
Colonoscopy and colorectal cancer mortality
 06 April 2018 
Eosinophilic esophagitis and health-related quality of life
 06 April 2018 
Microbiome in athletes vs sedentary subjects
 05 April 2018 
Laparoscopic Nissen fundoplication for GERD treatment
 05 April 2018 
Random biopsies for neoplasia in IBD
 05 April 2018 
Scoring system identifies cancer risk in Barrett's
 04 April 2018 
Alpha‐1 antitrypsin deficiency and liver disease
 04 April 2018 
PPI and risk of stroke
 04 April 2018 
Adjuvant chemotherapy for advanced colon cancer
 29 March 2018 
Prevention of metachronous gastric cancer
 29 March 2018 
Acute lower GI bleeding
 28 March 2018 
Decision aid used by IBD patients
 28 March 2018 
Transition for young adults with IBD
 28 March 2018 
Amitriptyline in functional dyspepsia
 27 March 2018 
Emergency department utilization for IBD 
 27 March 2018 
Management of hemorrhoids in the USA
 27 March 2018 
Adult ulcerative colitis
 26 March 2018 
Biological therapy response in IBD 
 26 March 2018 
Obesity and diverticulosis
 26 March 2018 
Practice guidelines for chronic constipation
 23 March 2018 
Health-related quality of life in eosinophilic esophagitis
 23 March 2018 
Genetics and chronic liver disease
 23 March 2018 
Global prevalence of H.pylori
 22 March 2018 
H. pyloris and gastric cancer
 22 March 2018 
Pancreatitis after IBS treatment 
 22 March 2018 
Mechanisms of action in patients with IBS
 21 March 2018 
Panel markers for early detection of colon cancer

 21 March 2018 
Blood test differentiates celiac disease
 21 March 2018 
Patient characteristics and colonoscopy preparation

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us